“India Had Medicines, But Not Cancer Drugs”| Aditya Chand Burman | Angie’s India Show

In this insightful segment from Angie’s India Show, Aditya Chand Burman, Non-Executive Director at Dabur India Ltd., takes us into a lesser-known but pivotal chapter of India’s pharmaceutical journey: the rise of oncology-focused pharmaceuticals.Aditya shares how, despite India’s deep roots in Ayurveda and traditional medicine, there was a time when advanced cancer drugs were largely unavailable in the country. While routine pharmaceuticals existed, oncology treatments demanded deep science, specialised infrastructure, and global regulatory standards—a gap his family recognised early on.With his father’s PhD research in oncology as the foundation, the Burman family set out to build what would become India’s largest oncology-focused pharmaceutical company at one point. In conversation with Anjaleka (Angie) Kripalani, Aditya reflects on the challenges of developing high-containment manufacturing facilities, meeting stringent international compliance norms, and eventually partnering with a global healthcare leader—Fresenius—a collaboration that evolved from supply discussions into a full acquisition.Follow Angie’s India Show & Anjaleka KripalaniInstagram: instagram.com/theworldofanjalekakriplaniFacebook: www.facebook.com/profile.php?id=61572895610850X (Twitter): x.com/ANGIESINDIASHOWLinkedIn: linkedin.com/company/anjaleka-angie-kripalani/postsSpotify: open.spotify.com/show/4n1hugp8Qx2Q71ul2juPQ2YouTube: youtube.com/channel/UCbeW_Z0kT5LHbZKnFXQz9gQ🎙️ Hosted by Anjaleka (Angie) Kripalani🎧 Watch the full episode now on YouTube | Follow @angiesindiashow for more inspiring conversations with India’s business visionaries.⚖ Disclaimer:This video represents the opinions of Anjaleka (Angie) Kripalani and her guest. The content reflects their personal views and experiences and is not intended to harm, defame, or misrepresent any individual, organization, or entity.© Copyright Notice:All rights of production are reserved by Anjaleka (Angie) Kripalani. Reproduction, reuse, or redistribution of this content is strictly prohibited unless expressly authorized by the creator.#AngiesIndiaShow #AdityaChandBurman #DaburPharma #IndianPharma #OncologyIndia #CancerCareIndia #HealthcareInnovation #BusinessLegacy #ScienceAndLeadership #IndianEntrepreneurs #LegacyAndInnovation #IndiaRising #AngieKripalani